Source: Eur Respir J 2015; 45: 1119-1131
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Olaru Ioana Diana, von Groote-Bidlingmaier Florian, Heyckendorf Jan, Yew Wing Wai, Lange Christoph, Chang Kwok Chiu. Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J 2015; 45: 1119-1131

Member's Comments

No comment yet.

Related content which might interest you: Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective Source: Breathe 2015; 11:71-72 Year: 2015 What's new in the management of CAP? Source: Annual Congress 2012 - New guidelines in respiratory infections Year: 2012 Atypical mycobacteriosis : new drugs, new strategies Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease Year: 2004 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives Source: Eur Respir Rev, 28 (152) 190035; 10.1183/16000617.0035-2019 Year: 2019 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 What's new in sarcoidosis management? Source: Annual Congress 2013 –ME5 What's new in sarcoidosis management? Year: 2013 Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe? Source: Eur Respir J 2016; 48: 1230-1233 Year: 2016 Towards the elimination of tuberculosis: challenges ahead from a European perspective Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis" Year: 2012 Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis Source: Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018 Year: 2018 Biomarker development in asthma from a patient's perspective Source: Breathe, 15 (4) 277; 10.1183/20734735.0303-2019 Year: 2019 Moving tuberculosis vaccines from theory to practice Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Key patients' needs: a patient's perspective Source: Eur Respir Monogr 2016; 71: 243-252 Year: 2016 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is science enough to tackle the epidemic? Source: Eur Respir J 2007; 29: 423-427 Year: 2007